Eton Pharmaceuticals, Inc. (NasdaqGM: ETON)
Health Care · Pharmaceuticals · US
$55.76
+1.00% today · +172.2% 1Y
Eton Pharmaceuticals, Inc. (NasdaqGM: ETON) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.58B and employs 44 people.
Over the last twelve months the share price has gained 172.2%, trading between 14.27 and 66.37.
Tweenvest scores Eton Pharmaceuticals, Inc. across four factors: quality 64/100, value 14/100, growth 100/100. Its strongest factor is growth.
ETON price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.58B
- Revenue (TTM)
- $105.59M
- P/E
- 128.99
- EPS
- 0.43
- Dividend yield
- —
- Beta (5Y)
- 0.90
- 52-week high
- $66.37
- 52-week low
- $14.27
- Avg volume (3M)
- —
- Shares outstanding
- 28.58M
- Employees
- 44
- Next earnings
- —
About Eton Pharmaceuticals, Inc.
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
- ISIN
- US29772L1089
- Founded
- 2017
- Listed since
- Nov 14, 2018
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Consun Pharmaceutical Group LimitedSEHK: 1681 | $1.59B | HK$14.85 | +0.81% |
| ANI Pharmaceuticals, Inc.NasdaqGM: ANIP | $1.58B | $73.79 | -0.14% |
| CSPC Hunan Jingfeng Pharmaceutical Co., Ltd.SZSE: 000908 | $1.58B | CN¥6.02 | +0.50% |
| Sopharma ADBUL: SFA | $1.58B | €2.62 | -0.38% |
| Mezzion Pharma Co.,Ltd.KOSDAQ: A140410 | $1.57B | ₩69,000.00 | +1.47% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.SZSE: 300357 | $1.56B | CN¥19.99 | -1.67% |
| Square Pharmaceuticals PLC.DSE: SQURPHARMA | $1.56B | Tk217.10 | -0.55% |
| Phibro Animal Health CorporationNasdaqGM: PAHC | $1.56B | $37.75 | -1.44% |
Figures last refreshed Oct 11, 2026.